Cancer BiologybioRxivPreprint
The HLA-E/NKG2A axis identifies a therapeutic vulnerability in BCG-unresponsive bladder cancer
Bérengère Salomé, Haocheng Yu, Daniel L Ranti…·Amir Horowitz
This study identifies the HLA-E/NKG2A axis as a therapeutic target in BCG-unresponsive bladder cancer by showing its role in immune evasion and impaired effector cell function.
5 citations